Related Experiment Video
Updated: Mar 23, 2026
08:53
A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
Published on: September 15, 2021
3.3K
Therapeutic activity of modified U1 core spliceosomal particles
Malgorzata Ewa Rogalska1, Mojca Tajnik1, Danilo Licastro2
1Human Molecular Genetics, International Centre for Genetic Engineering and Biotechnology, Padriciano 99, 34149 Trieste, Italy.
Nature Communications
|April 5, 2016
Summary
Engineered U1 small nuclear RNAs (snRNAs) can correct exon skipping mutations. This study shows exon-specific U1 snRNA (ExSpeU1) therapy improves spinal muscular atrophy outcomes in mice and identifies key structural elements for splicing rescue.
Area of Science:
- Molecular Biology
- Genetics
- RNA Therapeutics
Background:
- Exon skipping is a common mutation type leading to genetic disorders.
- U1 small nuclear RNA (snRNA) plays a critical role in pre-mRNA splicing.
- Current therapeutic strategies for exon skipping are limited.
Purpose of the Study:
- To evaluate the therapeutic potential of exon-specific U1 snRNA (ExSpeU1) particles.
- To determine the structural requirements for ExSpeU1-mediated splicing correction.
- To assess ExSpeU1 efficacy in a relevant disease model.
Main Methods:
- Development and testing of engineered ExSpeU1 particles.
- In vivo studies using a severe spinal muscular atrophy mouse model.
- In vitro RNA mutant analysis and protein silencing experiments.
Main Results:
- ExSpeU1 therapy in a spinal muscular atrophy mouse model increased SMN2 exon 7 inclusion and SMN protein production, extending lifespan.
- In vitro studies demonstrated that U1A protein is dispensable for ExSpeU1 activity.
- The 70K and stem loop IV elements of U1 snRNA were identified as crucial for mediating splicing rescue by improving exon and intron definition.
Conclusions:
- Precisely engineered U1 snRNA particles (ExSpeU1) show significant therapeutic potential.
- ExSpeU1 can correct exon skipping mutations and improve disease outcomes.
- This approach offers a promising strategy for treating genetic disorders caused by exon skipping.
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
4
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
4
01:32RNA Splicing
61.3K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
61.3K
02:47Ribozymes
13.7K
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can...
Ribozymes can...
13.7K
02:47Ribozymes
3.7K
3.7K
01:52Eukaryotic Transcription Inhibitors
11.3K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.3K
01:25Inhibitors of Bacterial Protein Synthesis
17
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
17